Service overview
Our radiolabeling and quality control service delivers purified, characterized radiolabeled compounds for preclinical pharmacokinetic, biodistribution, and efficacy studies. We work with a broad range of isotopes — including Lu-177, I-125, C-14, tritium, and Zr-89 — and offer both research-grade and quality-controlled options. Each project begins with isotope selection and conjugation strategy, followed by reaction optimization (chemical or enzymatic), purification via HPLC or solid-phase extraction, and a comprehensive quality control panel.
Quality control includes radio-TLC, radio-HPLC, mass confirmation, specific activity measurement, and radiochemical purity determination (target ≥ performance scoped per project). Stability studies under relevant storage and biological conditions are conducted and documented. The final deliverable is a ready-to-use radiolabeled product accompanied by a detailed certificate of analysis, supporting your downstream preclinical or early-phase clinical investigations.
What we offer
Custom Radiolabeling
Targeted conjugation and radiolabeling of small molecules, peptides, antibodies, and proteins with your isotope of choice. We optimize reaction conditions to achieve high specific activity and radiochemical yield.
Quality Control Development & Validation
Development and validation of QC methods (radio-HPLC, radio-TLC, mass spectrometry) to ensure batch-to-batch consistency. Analytical protocols are tailored to the compound and intended use.
Regulatory & Documentation Support
Comprehensive documentation including certificate of analysis, stability reports, and analytical data packages. For GMP projects, we support IMPD sections and regulatory submission readiness.
Workflow
Deliverables
| Deliverable | Description |
|---|---|
| Purified Radiolabeled Compound | Scoped per project after consultation |
| Certificate of Analysis (CoA) | Documents radiochemical purity, specific activity, identity confirmation, and QC test results. Includes method references and acceptance criteria. |
| Stability Study Report | Data on radiochemical stability over time under defined storage conditions and in relevant biological matrices (e.g., serum). |
| QC Method Development Summary | Description of analytical methods developed or adapted for your compound, including validation parameters (linearity, precision, accuracy). |
| Analytical Data Package | Full set of radio-HPLC/radio-TLC chromatograms, mass spectra, and specific activity calculations for each batch. |
Why choose us
End-to-End Service Integration
From isotope procurement and radiolabeling through QC, stability, and documentation, we manage the entire workflow. This reduces handoffs and accelerates your project timeline.
GMP-Ready Operations
Our radiolabeling and QC processes can be scaled to GMP standards for investigational medicinal product (IMP) manufacturing, including QP release and regulatory dossier support.
Experienced Radiochemistry Team
Our scientists have deep expertise in handling a wide range of isotopes and conjugation chemistries, ensuring robust labeling strategies for diverse molecular formats.
Flexible Engagement Models
We tailor the scope to your stage — whether you need a one-off labeling batch, full method development with validation, or integrated CMC support for IND/CTA submission.
References
Further Reading
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
View articleReady to start your project?
Our team is ready to discuss your radiolabeling needs, from isotope selection and method development to full GMP production. Contact us to review your target molecule and receive a tailored project proposal.